Mark Christianson, Market Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 10,000 shares at $3.18 ($32K) on 2026-06-30, disclosed to the SEC on 2026-07-02.
Seasonal sale ($32k) by Market Development Director — this insider has traded NMTC in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |
| NMTC | SELL | 2025-06-05 | $6K | — | Filing → |